Enovis (ENOV) FCF Margin Growth (3y) (2013 - 2026)
Enovis (ENOV) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 60.00 |
| 10 | Enovis | 1.51 Bn | 1.50 Bn | 359.25 Mn | 737.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 737.00 |
| Apr 3, 2026 | 76.00 |
| Dec 31, 2025 | 2,341.00 |
| Oct 3, 2025 | 568.00 |
| Jul 4, 2025 | 1,290.00 |
| Apr 4, 2025 | 223.00 |
| Dec 31, 2024 | -1,017.00 |
| Sep 27, 2024 | -1,847.00 |
| Jun 28, 2024 | -2,238.00 |
| Mar 29, 2024 | -3,339.00 |
| Dec 31, 2023 | -265.00 |
| Sep 29, 2023 | -510.00 |
| Jun 30, 2023 | -488.00 |
| Mar 31, 2023 | -874.00 |
| Dec 31, 2022 | -2,232.00 |
| Sep 30, 2022 | -261.00 |
| Jul 1, 2022 | -1,704.00 |
| Apr 1, 2022 | 387.00 |
| Dec 31, 2021 | -29.00 |
| Oct 1, 2021 | 907.00 |